Prometheus Laboratories Announces the Launch of PredictrPK™ IFX, A Revolutionary Test Enabling Precision-Guided Dosing for Inflammatory Bowel Disease

/PRNewswire/ -- Prometheus Laboratories Inc. ("Prometheus"), a leader of precision healthcare, announced today the launch of PredictrPK IFX, a test that aids...

Related Keywords

New York ,United States ,Thierry Dervieux ,Leonard Feinstein ,Marla Dubinsky ,Icahn School Of Medicine At Mount Sinai ,Prometheus Laboratories Inc ,Clinical Center At Mount Sinai Hospital ,Pediatric Gastroenterology ,Icahn School ,Mount Sinai ,Mount Sinai Hospital ,Inflammatory Bowel ,Chief Scientific Officer ,Inflammatory Bowel Disease ,Prometheus Laboratories ,Nc ,